- Filed
- May 9, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 7, 2024 | 212.01M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 191M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 187.11M sh |
| Capex | Q1 2024 · Mar 31, 2024 | $409K |
| Capex | Q1 2024 · Mar 31, 2023 | $2.68M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$15.05M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$37.69M |
| Long Term Debt | Q1 2024 · Mar 31, 2024 | $4.87M |
| Long Term Debt | Q1 2024 · Dec 31, 2023 | $5.25M |
| Short Term Debt | Q1 2024 · Mar 31, 2024 | $1.9M |
| Short Term Debt | Q1 2024 · Dec 31, 2023 | $55.2M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $6.65M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $8.93M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $67.25M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $86.04M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $194.64M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $193.9M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $35.1M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $104.3M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $118.04M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $188.72M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $85.73M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $174.75M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $185.29M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $274.76M |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | −$0.11 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.02 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | −$0.11 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.02 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $14.83M |
| Sga Expense restated | Q1 2024 · Mar 31, 2023 | $13.23M |
| Rd Expense | Q1 2024 · Mar 31, 2024 | $6.94M |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $12.64M |
| Net Income | Q1 2024 · Mar 31, 2024 | −$21.28M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$3.05M |
| Operating Income | Q1 2024 · Mar 31, 2024 | −$16.53M |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$21.23M |
| Gross Profit | Q1 2024 · Mar 31, 2024 | $5.24M |
| Gross Profit restated | Q1 2024 · Mar 31, 2023 | $4.64M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2024 | $15.9M |
| Cost Of Revenue restated | Q1 2024 · Mar 31, 2023 | $44.02M |
| Revenue | Q1 2024 · Mar 31, 2024 | $21.13M |
| Revenue restated | Q1 2024 · Mar 31, 2023 | $48.67M |